NEUTRISCI INTERNATIONAL INC. INCREASES FINANCING TO $1.15 MILLION

NeutriSci International Inc. (“NeutriSci” or the “Company”) the innovator and pioneer behind neuenergy(R) is pleased to announce that it has elected to increase the size [...]

NEUTRISCI PROVIDES UPDATE ON CALIFORNIA MANUFACTURING AND DISTRIBUTION PARTNERSHIPS

Vancouver, British Columbia – December 12, 2019 – NeutriSci International Inc. (“NeutriSci” or the “Company”) (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9) the innovator and pioneer behind [...]

NEUTRISCI AND CRYOPHARM EXPAND EXISTING MANUFACTURING AND DISTRIBUTION AGREEMENT TO INCLUDE NEVADA

Vancouver, British Columbia – October 22, 2019 – NeutriSci International Inc. (“NeutriSci”) (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9) is pleased to provide a further update on its manufacturing [...]

NEUTRISCI EXPANDS PARTNERSHIP WITH CRYOPHARM AND NUTRITIONAL HIGH

NeutriSci International Inc. (“NeutriSci”) the innovator and pioneer behind neuenergy is pleased to announce that it has expanded its previously announced partnerships with Cryopharm [...]

NEUTRISCI ENTERS INTO LOI WITH FALCON TECHNOLOGIES INC. dba ECOGROWTH STRATEGIES TO MANUFACTURE SUBLINGUAL CBD PRODUCTS

– Signing of definitive agreement expected in early Q2 – First orders expected in early Q3 Vancouver, British Columbia – March 25, 2019 – Neutrisci International Inc. (the [...]

NEUTRISCI ANNOUNCES EXCLUSIVE LICENSING AGREEMENT FOR CBD TABLET MANUFACTURING & DISTRIBUTION WITH LASANTA BOTANICALS LTD.

Vancouver, British Columbia – December 6, 2018 – NeutriSci International Inc. (“NeutriSci”) (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9) has entered into a memorandum of [...]

NEUTRISCI AND NUTRITIONAL HIGH ENTER INTO AGREEMENT TO DEVELOP, MANUFACTURE & DISTRIBUTE CANNABIS INFUSED PRODUCTS

Vancouver, British Columbia – May 30, 2018 – NeutriSci International Inc. (“NeutriSci”) (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9) the innovator and pioneer behind neuenergy®, and [...]

NEUTRISCI FILES PATENT APPLICATION

Vancouver, British Columbia – March 1, 2018 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9) the innovator and [...]

NEUTRISCI AND LEXARIA BIOSCIENCE ENTER GLOBAL LICENSING AGREEMENT

Vancouver, British Columbia – February 26th, 2018 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU, OTCQB: NRXCF, Frankfurt: 1N9) and Lexaria [...]

NEUTRISCI ANNOUNCES A MAJOR R&D MOU WITH SCIENTUS PHARMA TO DEVELOP A MEDICAL CANNABINOID RETAIL PRODUCT

Vancouver, British Columbia – January 8, 2018 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9), the innovator and [...]

page 1 of 2